Board of Directors | Keystone Symposia

Keystone Symposia Board of Directors

Keystone Symposia is governed by a volunteer Board of Directors composed of distinguished scientists from academia, industry, government and foundations. The board meets three times each year to provide guidance and direction to Keystone Symposia staff, and to participate with the larger Scientific Advisory Board in the determination of future conference topics and organizers. Members serve 3-year terms, and up to 3 consecutive terms. New board members are identified and recruited by the Nominating Committee of the Board, and elected by the full Board.

Board of Directors

James W. Baumgartner, Ph.D.

President and Chief Executive Officer
Keystone Symposia on Molecular and Cellular Biology

Board of Directors

Morris J. Birnbaum, M.D., Ph.D.

Retired CSO
Pfizer Inc.

Committee Roles

Chair, Development Subcommittee

Board of Directors

Nancy J. Brown, M.D.

Jean and David W. Wallace Dean of Medicine and
C.N.H. Long Professor of Internal Medicine
Yale School of Medicine

Board of Directors

Cherié L. Butts, Ph.D.

Medical Director
Digital & Quantitative Medicine
Biogen, Inc.

Board of Directors

Ian M. Colrain, Ph.D.

President and CEO
MRIGlobal

Committee Roles

Treasurer, Board of Directors
Chair, Audit Subcommittee
Chair, Finance Subcommittee

Board of Directors

Richard D. DiMarchi, Ph.D.

Distinguished Professor
Chemistry
Indiana University

Board of Directors

Maria C. Freire, Ph.D.

Principal
The Freire Group

Board of Directors

Mattias Fyrenius

Publishing Director
Bonnier Carlsen

Board of Directors

Margaret A. Goodell, Ph.D.

Professor and Chair
Department of Molecular and Cellular Biology
Director of Stem Cells & Regenerative Medicine Center
Vivian L. Smith Chair of Regenerative Medicine
Baylor College of Medicine